{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:36:11Z","timestamp":1787240171814,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12672-014-0179-9","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T09:16:42Z","timestamp":1398071802000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Translating Extranuclear Steroid Receptor Signaling to Clinical Medicine"],"prefix":"10.1007","volume":"5","author":[{"given":"Ellis R.","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"179_CR1","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1210\/en.2011-1470","volume":"152","author":"S Hammes","year":"2011","unstructured":"Hammes S, Levin ER (2011) Recent advances in extra-nuclear steroid receptor actions. Endocrinology 152:4489\u20134495","journal-title":"Endocrinology"},{"key":"179_CR2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1210\/me.2004-0486","volume":"19","author":"L Bjornstrom","year":"2005","unstructured":"Bjornstrom L, Sjoberg M (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833\u2013842","journal-title":"Mol Endocrinol"},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1210\/me.2012-1191","volume":"26","author":"F O\u2019Mahony","year":"2012","unstructured":"O\u2019Mahony F, Pedram A, Razandi M, Levin ER (2012) Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer cells. Mol Endocrinol 26:2058\u20132070","journal-title":"Mol Endocrinol"},{"key":"179_CR4","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1074\/jbc.M806249200","volume":"284","author":"A Pedram","year":"2009","unstructured":"Pedram A, Razandi M, Kim JK, O\u2019Mahony F, Lee E, Luderer U, Levin ER (2009) Developmental phenotype of a membrane only estrogen receptor \u03b1 (MOER) mouse. J Biol Chem 284:3488\u20133495","journal-title":"J Biol Chem"},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"RA36","DOI":"10.1126\/scisignal.2004013","volume":"6","author":"A Pedram","year":"2013","unstructured":"Pedram A, Razandi M, O\u2019Mahony F, Harvey H, Harvey BJ, Levin ER (2013) Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling. Sci Signal 6:RA36","journal-title":"Sci Signal"},{"key":"179_CR6","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1038\/onc.2011.447","volume":"31","author":"H Werner","year":"2012","unstructured":"Werner H (2012) Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene 31:2703\u20132714","journal-title":"Oncogene"},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","volume":"136","author":"H Masuda","year":"2012","unstructured":"Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN, Ueno NT (2012) Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat 136:331\u2013345","journal-title":"Breast Cancer Res Treat"},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.breast.2012.09.008","volume":"22","author":"DL Nielsen","year":"2013","unstructured":"Nielsen DL, K\u00fcmler I, Palshof JA, Andersson M (2013) Efficacy of HER2-targeted therapy in metastatic breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Breast 22:1\u201312","journal-title":"Breast"},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","volume":"62","author":"CK Osborne","year":"2011","unstructured":"Osborne CK, Schiff R (2011) Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 62:233\u2013247","journal-title":"Annu Rev Med"},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nature07483","volume":"456","author":"A Hurtado","year":"2008","unstructured":"Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS (2008) Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456:663\u2013666","journal-title":"Nature"},{"key":"179_CR11","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/j.1460-2075.1996.tb00471.x","volume":"15","author":"A Migliaccio","year":"1996","unstructured":"Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F (1996) Tyrosine kinase\/p21ras\/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292\u20131300","journal-title":"EMBO J"},{"key":"179_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1210\/me.2004-0306","volume":"19","author":"A Skildum","year":"2005","unstructured":"Skildum A, Faivre E, Lange CA (2005) Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19:327\u2013339","journal-title":"Mol Endocrinol"},{"key":"179_CR13","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1074\/jbc.M205692200","volume":"278","author":"M Razandi","year":"2003","unstructured":"Razandi M, Pedram A, Parks ST, Levin ER (2003) Proximal events in ER signaling from the plasma membrane. J Biol Chem 278:2701\u20132712","journal-title":"J Biol Chem"},{"key":"179_CR14","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1210\/en.2007-0240","volume":"148","author":"RX Song","year":"2007","unstructured":"Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ (2007) Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 148:4091\u20134101","journal-title":"Endocrinology"},{"key":"179_CR15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/emmm.201201615","volume":"4","author":"C Poulard","year":"2012","unstructured":"Poulard C, Treilleux I, Lavergne E, Bouchekioua-Bouzaghou K, Goddard-Leon S, Chabaud S, Tredan O, Corbo L, Le Romancer M (2012) Activation of rapid estrogen signaling in aggressive human breast cancers. EMBO Mol Med 4:1200\u20131213","journal-title":"EMBO Mol Med"},{"key":"179_CR16","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1128\/MCB.24.13.5900-5913.2004","volume":"24","author":"M Razandi","year":"2004","unstructured":"Razandi M, Pedram A, Rosen EM, Levin ER (2004) BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24:5900\u20135913","journal-title":"Mol Cell Biol"},{"key":"179_CR17","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1091\/mbc.E02-03-0153","volume":"13","author":"M Marino","year":"2002","unstructured":"Marino M, Acconcia F, Bresciani F, Weisz A, Trentalance A (2002) Distinct nongenomic signal transduction pathways controlled by 17\u03b2-estradiol regulate DNA synthesis and cyclin D1 gene transcription in HepG2 cells. Mol Biol Cell 13:3720\u20133729","journal-title":"Mol Biol Cell"},{"key":"179_CR18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2119\/molmed.2011.00001","volume":"19","author":"H Kim","year":"2013","unstructured":"Kim H, Abd ZY, Elmageed JJ, Naura AS, Abdel-Mageed AB, Varughese S, Paul D, Alahari S, Catling A, Kim JG, Hamid Boulares A (2013) PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth. Mol Med 19:253\u2013262","journal-title":"Mol Med"},{"key":"179_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1128\/MCB.01539-06","volume":"27","author":"EJ Faivre","year":"2007","unstructured":"Faivre EJ, Lange CA (2007) Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1\/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27:466\u2013480","journal-title":"Mol Cell Biol"},{"key":"179_CR20","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1091\/mbc.E09-01-0085","volume":"20","author":"A Pedram","year":"2009","unstructured":"Pedram A, Razandi M, Evinger AJ, Lee E, Levin ER (2009) Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell 20:3374\u20133389","journal-title":"Mol Biol Cell"},{"key":"179_CR21","doi-asserted-by":"crossref","unstructured":"Dressing, Gwen E, Todd P Knutson, Matthew J Schiewer, Andrea R Daniel, Christy R Hagan, Caroline H Diep, Karen E Knudsen, Carol A Lange (2014) Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells. Mol Endocrinol Feb 25:me20131196","DOI":"10.1210\/me.2013-1196"},{"key":"179_CR22","doi-asserted-by":"publisher","first-page":"11122","DOI":"10.1073\/pnas.1005262107","volume":"107","author":"B York","year":"2010","unstructured":"York B, Chundong Y, Sagen JV, Liu Z, Nikolai BC, Ray-Chang W, Finegold M, Jianming X, O\u2019Malley BW (2010) Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology. Proc Natl Acad Sci 107:11122\u201311127","journal-title":"Proc Natl Acad Sci"},{"key":"179_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1210\/me.2009-0438","volume":"24","author":"TG Bredfeldt","year":"2010","unstructured":"Bredfeldt TG, Leigh Greathouse K, Safe SH, Hung M-C, Bedford MT, Walker CL (2010) Xenoestrogen-induced regulation of EZH2 and histone methylation via estrogen receptor signaling to PI3K\/AKT. Mol Endocrinol 24:993\u20131006","journal-title":"Mol Endocrinol"},{"key":"179_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1091\/mbc.E11-07-0638","volume":"23","author":"A Pedram","year":"2012","unstructured":"Pedram A, Razandi M, Deschenes R, Levin ER (2012) DHHC 7 and 21 are palmitoylacyltranferases for sex steroid receptors. Mol Biol Cell 23:188\u2013199","journal-title":"Mol Biol Cell"},{"key":"179_CR25","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrocich H, McTiernan A, Investigators WHI (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289:3243\u20133253","journal-title":"JAMA"},{"key":"179_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molcel.2006.10.011","volume":"24","author":"GP Vicent","year":"2006","unstructured":"Vicent GP, Cecilia Ballar\u00e9 A, Nacht S, Clausell J, Subtil-Rodriguez A, Quiles I, Jordan A, Beato M (2006) Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 24:367\u2013381","journal-title":"Mol Cell"},{"key":"179_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.95","author":"D Reyes","year":"2013","unstructured":"Reyes D, Carlos B, Giuliano C, Daniel S, Bag\u00f3 JR, Jose B, Miguel B (2013) Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins. Oncogene. doi:10.1038\/onc.2013.95","journal-title":"Oncogene"},{"key":"179_CR28","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/sj.onc.1203032","volume":"18","author":"H Peterziel","year":"1999","unstructured":"Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC (1999) Rapid signaling by androgen receptor in prostate cancer cells. Oncogene 18:6322\u20136329","journal-title":"Oncogene"},{"key":"179_CR29","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.1158\/0008-5472.CAN-04-1121","volume":"64","author":"E Unni","year":"2004","unstructured":"Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M (2004) Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156\u20137168","journal-title":"Cancer Res"},{"key":"179_CR30","first-page":"822","volume":"76","author":"A Sen","year":"2011","unstructured":"Sen A, Prizant H, Hammes SR (2011) Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology. Steroids 76:822\u2013828","journal-title":"Steroids"},{"key":"179_CR31","doi-asserted-by":"publisher","first-page":"28787","DOI":"10.1074\/jbc.M110.134064","volume":"285","author":"A Sen","year":"2010","unstructured":"Sen A, O\u2019Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR (2010) Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 285:28787\u201328795","journal-title":"J Biol Chem"},{"key":"179_CR32","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1172\/JCI62044","volume":"122","author":"A Sen","year":"2012","unstructured":"Sen A, De Castro I, Defranco DB, Deng F-M, Melamed J, Kapur P, Raj GV, Rossi R, Hammes SR (2012) Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest 122:2469\u20132481","journal-title":"J Clin Invest"},{"key":"179_CR33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1074935","volume":"298","author":"S Kousteni","year":"2002","unstructured":"Kousteni S, Chen JR, Bellido T, Han L, Ali AA, O\u2019Brien CA, Plotkin L, Fu Q, Mancino AT, Wen Y, Vertino AM, Powers CC, Stewart SA, Ebert R, Parfitt AM, Weinstein RS, Jilka RL, Manolagas SC (2002) Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298:843\u2013846","journal-title":"Science"},{"key":"179_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI200317261","volume":"111","author":"S Kousteni","year":"2003","unstructured":"Kousteni S, Han L, Chen J-R, Almeida M, Plotkin LI, Bellido T, Manolagas SC (2003) Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651\u20131664","journal-title":"J Clin Invest"},{"key":"179_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1210\/me.2012-1368","volume":"27","author":"SM Bartell","year":"2013","unstructured":"Bartell SM, Han L, Kim H-n, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Chambliss KL, Shaul PW, Roberson PK, Weinstein RS, Jilka RL, Almeida M, Manolagas SC (2013) Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass. Mol Endocrinol 27:649\u2013656","journal-title":"Mol Endocrinol"},{"key":"179_CR36","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.01087.2002","volume":"284","author":"MA Cavasin","year":"2003","unstructured":"Cavasin MA, Sankey SS, Ai-Li Y, Menon S, Yang X-P (2003) Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 284:H1560\u2013H1569","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"179_CR37","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","volume":"115","author":"M Satoh","year":"2007","unstructured":"Satoh M, Matter CM, Ogita H, Takeshita K, Wang C-Y, Dorn GW II, Liao JK (2007) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115:3197\u20133204","journal-title":"Circulation"},{"key":"179_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/cvr\/cvm081","volume":"77","author":"V Jazbutyte","year":"2008","unstructured":"Jazbutyte V, Arias-Loza PA, Kai H, Widder J, Govindaraj V, von Poser-Klein C, Bauersachs J, Fritzemeier K-H, Hegele-Hartung C, Neyses L, Ertl G, Pelzer T (2008) Ligand-dependent activation of ER lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized SHR. Cardiovasc Res 77:774\u2013781","journal-title":"Cardiovasc Res"},{"key":"179_CR39","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/en.2008-0133","volume":"149","author":"A Pedram","year":"2008","unstructured":"Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER (2008) Estrogen inhibits cardiac hypertrophy: role of estrogen receptor beta to inhibit calcineurin. Endocrinology 149:3361\u20133369","journal-title":"Endocrinology"},{"key":"179_CR40","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1210\/en.2013-1358","volume":"154","author":"A Pedram","year":"2013","unstructured":"Pedram A, Razandi M, Korach K, Narayanan R, Dalton J, Levin ER (2013) ER\u03b2 selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice. Endocrinology 154:4352\u20134364","journal-title":"Endocrinology"},{"key":"179_CR41","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1091\/mbc.E13-08-0444","volume":"24","author":"A Pedram","year":"2013","unstructured":"Pedram A, Razandi M, Narayanan R, Dalton J, McKinsey TA, Levin ER (2013) Estrogen regulates histone deacetylases to prevent cardiac hypertrophy. Mol Biol Cell 24:3805\u20133818","journal-title":"Mol Biol Cell"},{"key":"179_CR42","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1210\/me.2010-0154","volume":"24","author":"A Pedram","year":"2010","unstructured":"Pedram A, Razandi M, O\u2019Mahony F, Lubahn D, Levin ER (2010) Estrogen receptor beta prevents cardiac fibrosis. Mol Endocrinol 24:2152\u20132165","journal-title":"Mol Endocrinol"},{"key":"179_CR43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1152\/japplphysiol.01349.2011","volume":"113","author":"RD Nadadur","year":"2012","unstructured":"Nadadur RD, Umar S, Wong G, Eghbali M, Iorga A, Matori H, Partow-Navid R, Eghbali M (2012) Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension. J Appl Physiol 113:149\u2013158","journal-title":"J Appl Physiol"},{"key":"179_CR44","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1172\/JCI38291","volume":"120","author":"KL Chambliss","year":"2010","unstructured":"Chambliss KL, Qian W, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW (2010) Non-nuclear estrogen receptor a signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 120:2319\u20132330","journal-title":"J Clin Invest"},{"key":"179_CR45","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1073\/pnas.0306948101","volume":"101","author":"S-H Yang","year":"2004","unstructured":"Yang S-H, Liu R, Perez EJ, Wen Y, Stevens SM Jr, Valencia T, Brun-Zinkernagel A-M, Prokai L, Will Y, Dykens J, Koulen P, Simpkins JW (2004) Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A 101:4130\u20134135","journal-title":"Proc Natl Acad Sci U S A"},{"key":"179_CR46","doi-asserted-by":"publisher","first-page":"E1011","DOI":"10.1152\/ajpendo.00508.2003","volume":"28","author":"J-Q Chen","year":"2004","unstructured":"Chen J-Q, Delannoy M, Cooke C, Yager JD (2004) Mitochondrial localization of ER\u03b1 and ER\u03b2 in human MCF-7 cells. Am J Physiol Endocrinol Metab 28:E1011\u2013E1022","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"179_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2005.08.001","volume":"1746","author":"J-Q Chen","year":"2005","unstructured":"Chen J-Q, Yager JD, Russo J (2005) Regulation of mitochondrial respiratory chain structure and function by estrogens\/estrogen receptors and potential physiological\/pathophysiological implications. Biochim Biophys Acta 1746:1\u201317","journal-title":"Biochim Biophys Acta"},{"key":"179_CR48","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1091\/mbc.E05-11-1013","volume":"17","author":"A Pedram","year":"2006","unstructured":"Pedram A, Razandi M, Wallace DC, Levin ER (2006) Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 17:2125\u20132137","journal-title":"Mol Biol Cell"},{"key":"179_CR49","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1038\/onc.2012.335","volume":"32","author":"M Razandi","year":"2013","unstructured":"Razandi M, Ali Pedram V, Jordan C, Fuqua S, Levin ER (2013) Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer. Oncogene 32:3274\u20133285","journal-title":"Oncogene"},{"key":"179_CR50","doi-asserted-by":"publisher","first-page":"10228","DOI":"10.1016\/j.biomaterials.2013.09.003","volume":"34","author":"SK Cho","year":"2013","unstructured":"Cho SK, Pedram A, Levin ER, Kwon YJ (2013) Acid-degradable core-shell nanoparticles for reversed Tamoxifen-resistance in breast cancer by silencing manganese superoxide dismutase (MnSOD). Biomaterials 34:10228\u201310237","journal-title":"Biomaterials"},{"key":"179_CR51","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1210\/me.2010-0125","volume":"24","author":"GF Zhang","year":"2010","unstructured":"Zhang GF, Yanamala N, Lathrop KL, Zhang L, Klein-Seetharaman J, Srinivas H (2010) Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells. Mol Endocrinol 24:1737\u20131747","journal-title":"Mol Endocrinol"},{"key":"179_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/en.2012-1870","volume":"154","author":"N Tabatadze","year":"2013","unstructured":"Tabatadze N, Smejkalova T, Woolley CS (2013) Distribution and posttranslational modification of synaptic ER\u03b1 in the adult female rat hippocampus. Endocrinology 154:819\u2013830","journal-title":"Endocrinology"},{"key":"179_CR53","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.pharmtox.47.120505.105219","volume":"47","author":"CS Woolley","year":"2007","unstructured":"Woolley CS (2007) Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol 47:657\u2013680","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"179_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.nbd.2013.06.004","volume":"58","author":"AI Rodriguez-Perez","year":"2013","unstructured":"Rodriguez-Perez AI, Dominguez-Meijide A, Lanciego JL, Guerra MJ, Labandeira-Garcia JL (2013) Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson\u2019s disease. Neurobiol Dis 58:209\u2013219","journal-title":"Neurobiol Dis"},{"key":"179_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12975-012-0230-5","volume":"4","author":"EC Koellhoffer","year":"2013","unstructured":"Koellhoffer EC, McCullough LD (2013) The effects of estrogen in ischemic stroke. Transl Stroke Res 4:390\u2013401","journal-title":"Transl Stroke Res"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-014-0179-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0179-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-014-0179-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T11:10:52Z","timestamp":1609758652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-014-0179-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1007\/s12672-014-0179-9","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]},"assertion":[{"value":"7 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}